1 What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia
2 Dementia: broad term for any acquired brain condition impairing mental function such that ADLs are impaired. Includes: Alzheimer s disease Multi-infarct dementia (due to strokes) Lewy body dementia Frontotemporal dementia many others
3 Outline for tonight Lewy body dementia Frontotemporal dementia Treatment Research Support programs
4 Outline for tonight Lewy body dementia PDD (Parkinson s Disease Dementia) LBD (Lewy body dementia) Frontotemporal dementia Behavioral variants Language variants Genetic variants Treatment Research Support programs
5 Some definitions : Dementia = any acquired brain condition that interferes with the ability to think and to carry out routine daily functions
6 Some definitions : Dementia = any acquired brain condition that interferes with the ability to think and to carry out routine daily functions Alzheimer s disease = the most common cause of dementia, characterized by plaques and tangles in brain
7 Some definitions : Dementia = any acquired brain condition that interferes with the ability to think and to carry out routine daily functions Alzheimer s disease = the most common cause of dementia, characterized by plaques and tangles in brain
8 Some definitions : Dementia = any acquired brain condition that interferes with the ability to think and to carry out routine daily functions Alzheimer s disease = the most common cause of dementia, characterized by plaques and tangles in brain Parkinson s disease = A disease of movement With dementia occurring Years after diagnosis
9 Some definitions : Dementia = any acquired brain condition that interferes with the ability to think and to carry out routine daily functions Alzheimer s disease = the most common cause of dementia, characterized by plaques and tangles in brain Parkinson s disease = A disease of movement with dementia occurring years after diagnosis
11 Cognitive Function in PD a motor disease without a significant cognitive component: Classical View: by the absence of any injury to the senses and to the intellect, (we conclude) that the morbid state does not involve the encephalon. ---James Parkinson, An Essay on the Shaking Palsy (1817)
12 Revised View: Cognitive impairment is a common feature of PD Cognitive impairment is a significant source of distress and disability
13 Dementia Prevalence of Cognitive Impairment in PD 20% of PD have mild cognitive impairment (MCI) at time of PD diagnosis 30-40% of all PD have dementia Up to 80% by 15 years into disease 4-6x greater than elderly without PD
14 What domains of mental function are affected in Parkinson s? Attention* Memory Executive function* Visuospatial function* Language function
15 Alzheimer s vs Parkinson s: Alzheimer s PD Dementia Attention Memory Executive Visuospatial Language
16 What causes cognitive decline in Parkinson s? Many causes Changes in neurotransmitters are part of the problem---but it s not the same neurotransmitters that cause the movement disorder
17 Motor Symptoms are Dopamine Responsive
18 Motor Symptoms are Dopamine Responsive
19 Motor Symptoms are Dopamine Responsive
20 Motor Symptoms are Dopamine Responsive
21 Cognitive symptoms are due to impairment in a different neurotransmitter: acetylcholine: Bohnen, Arch Neurol, 60:1745-8, 2003.
22 Bohnen, Arch Neurol, 60:1745-8, 2003.
23 Bohnen, Arch Neurol, 60:1745-8, 2003.
24 Bohnen, Arch Neurol, 60:1745-8, 2003.
25 Drugs to boost acetylcholine help in PD dementia:
28 Conclusions: Parkinson s dementia is distinct from Alzheimer s Neurotransmitters involved in dementia are distinct from the ones involved in impaired movements.
29 What is Lewy body dementia? A dementia characterized by: Parkinsonism Hallucinations Sensitivity to anti-psychotic medications Fluctuations Brain autopsy shows lewy bodies in the brain
30 What is Lewy body dementia? The cognitive profile looks like parkinson s dementia Brain autopsy shows lewy bodies in the brain
31 How is Lewy body dementia different from Parkinson s disease? In Parkinson s disease, the dementia appears several years after diagnosis of movement problems. In Lewy body dementia, the movement problems and the dementia come on together.
32 How is Lewy body dementia different from Parkinson s disease? Tremor is less common Slowness and stiffness are more symmetric Motor symptoms are less responsive to medication in lewy body dementia than in parkinson s disease
33 How is Lewy body dementia different from Parkinson s disease? In Parkinson s disease, hallucinations are promoted by the drugs used to treat Parkinson s disease. In Lewy body dementia, hallucinations appear without being triggered by any drugs.
34 What is Lewy body dementia? Sensitivity to antipsychotic medications is part of Lewy body dementia. Patients can become frozen from low doses of these medications Fluctuations in level of consciousness are also common in Lewy body dementia.
35 How is Lewy body dementia treated? Need to be careful with Parkinson s medicines, because they will increase hallucinations. Need to be careful with medicine for hallucinations, because it worsens parkinsonian motor symptoms. Some patients do well with medicines that increase acetylcholine.
36 The ability to increase brain acetylcholine is limited: Because acetylcholine also works on the stomach and intestines Most of the drugs that boost acetylcholine in brain also boost it in GI tract and cause nausea, vomiting, loose stools, diarrhea If only there was a way to boost acetylcholine in the brain without affecting the gut.
38 Research on Lewy body dementia 28 studies currently recruiting world-wide 1 study recruiting in Oregon
42 What can we do about hallucinations in Parkinson s dementia and Lewy body dementia The medications usually used for hallucinations make parkinsonism worse. One exception is clozapine, but there are risks with that drug which require weekly blood tests to monitor. A new approach to hallucinations in this population is needed.
47 Conclusions: New strategies for increasing acetylcholine in the brain may permit more effective treatment of Lewy body dementia. A new strategy for treating hallucinations in the setting of Parkinson s disease may eventually be applied to Lewy body dementia
48 Future directions for Lewy body dementia: Aimed at underlying pathology: Lewy bodies, the chief component of which is alpha synuclein:
49 Spread of Lewy bodies to thinking centers of the brain:
50 Experimental therapies trageting synuclein include: small molecule (ie, a pill) Immunotherapy (ie, antibodies, delivered by injection) Gene therapy
51 Support for Lewy body dementia: Alzheimer s Association Lewy Body Dementia Association
52 Frontotemporal dementia: Behavioral variant Language variant
53 Behavioral variant: disinhibited: 52 year old man: Trouble learning new tasks at work Gradual onset of disinhibited statements there is no filter Over-spends, over-tips Eats impulsively: Stuffs mouth full without swallowing, episodes of choking Acts impulsively: eg, jumped in white water with dog while out hiking
54 Behavioral variant: disinhibited: 52 year old man: Mmse =29/30 EXIT-25 =14/50 Normal neuro exam Bilateral frontotemporal atrophy on MRI scan
55 MRI in FTD:
56 Language variant: Primary progressive aphasia (PPA) 53 year old woman referred for declining language function Worked as a traveling motel clerk until one year prior to evaluation. Telephone calls to husband and sister became flat about years prior to eval. Laid off from work one year prior to eval.
57 Language variant-ppa She was referred to a local neurologist, who found normal EEG, normal MRI, and thought neurodegenerative disease unlikely. Social security examiner thought she was depressed and recommended ECT. Psychiatrist thought her language was impaired, doubted depression as the primary diagnosis, and referred her to another neurologist Chief complaint was difficulty with expressive language
58 Mental status exam mmse = 21/30 Orientation = 6/10 Attention = 2/5 ( DLORY ) Repetition = 0/1 obvious trouble with word-finding during spontaneous speech, to the point where even simple sentences were rarely fluent
59 labs Neuro exam: normal Brain MRI normal
60 Brain autopsy Frontotemporal dementia confirmed in both instances Note: Younger than Alzheimer s patients Memory is relatively preserved Behavior or language are markedly impaired With time, impairment generalizes and function declines
61 Brain autopsy Some variants of frontotemporal dementia, defined by brain autopsy: Pick s disease FTDP-17 Progressive supranuclear palsy Corticobasal degeneration
62 Genetics: FTDP-17 (rare) Progranulin (rare) C9ORF72: fairly common in familial FTD, also seen in sporadic cases
63 Genetics: FTDP-17 (rare) Progranulin (rare) C9ORF72: fairly common in familial FTD, also seen in sporadic cases The genetics does not predict the particular symptoms
64 Treatment of FTD SSRI s are recommended by most experts Otherwise symptomatic treatment on a caseby-case basis
65 Research on FTD 45 studies worldwide none in Oregon 7 in California, none are treatments
66 Support for FTD Association for Frontotemporal Dementia Cure PSP Alzheimer s Association
67 conclusions Lewy body dementia and frontotemporal dementia are distinct from Alzheimer s disease Ongoing research is under way to develop disease-modifying treatments. In the meantime, treatment is tailored to symptoms. Support for caregivers is available through a number of non-profit groups.
FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS Norman L. Foster, M.D. Director, Center for Alzheimer s Care, Imaging and Research Chief, Division of Cognitive Neurology, Department of Neurology
Clinical Differences Among Four Common Dementia Syndromes a program of Morningside Ministries Introduction Four clinical dementia syndromes account for 90% of all cases after excluding reversible causes
Dementia Update October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Outline New concepts in Alzheimer disease Biomarkers and in vivo diagnosis Future trends
Assessing and Managing the Patient with Cognitive Decline Center of Excellence For Alzheimer s Disease for State of NY Capital Region Alzheimer s Center of Albany Medical Center Earl A. Zimmerman, MD Professor
Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia
Delirium & Dementia Nicholas J. Silvestri, MD Outline Delirium vs. Dementia Neural pathways relating to consciousness Encephalopathy Stupor Coma Dementia Delirium vs. Dementia Delirium Abrupt onset Lasts
Mild Cognitive Impairment James Y Lin, DO, MHSA Program Director, LIGHT (GWEP) VP Senior Services & Adult Living Medical Director, LECOM Senior Living Center Director, LECOM Institute for Successful Aging
I read all the available books by other [people with] Alzheimer s disease but they never had quite the same problems as each other, or as me. I t s not like other diseases, where there is a standard set
P20.2. Characteristics of different types of dementia and challenges for the clinician, professor Danish Dementia Research Center Rigshospitalet, University of Copenhagen (Denmark) This project has received
DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that
What is frontotemporal dementia? Introduction Information in this introductory booklet is for anyone who wants to know more about frontotemporal dementia (FTD). This includes people living with FTD, their
What is PRESENTS DEMENTIA? WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: Memory Reasoning Planning Learning Attention Language Perception Behavior AS OF 2013 There
DEMENTIA WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient Progressive and disabling Not an inherent aspect of
Rarer causes of dementia Factsheet 442LP March 2015 Alzheimer s disease is the most common cause of dementia, but there are many rarer diseases and conditions that can lead to dementia, dementialike symptoms
MCI and Dementia Gerontechnology, 2016 Normal Cognitive Aging Process Aging does not equate to loss of all cognitive abilities Commonly Certain held misconception cognitive domains normally decline with
Parkinson s Disease in the Elderly A Physicians perspective Dr John Coyle Overview Introduction Epidemiology and aetiology Pathogenesis Diagnosis and clinical features Treatment Psychological issues/ non
Mid North Coast Rural Palliative Care Project Link Nurse Education 2004 Palliative Approach to the Person with Advanced Dementia Anne Sneesby CNC - ACAT To care for the dying is a very human opportunity
Disorders of Aging and Cognition Chapter 18 Slides & Handouts by Karen Clay Rhines, Ph.D. Northampton Community College Comer, Abnormal Psychology, 8e Disorders of Aging and Cognition Dementia deterioration
Parkinson s Disease Update Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s What is a movement disorder? Neurological disorders that affect ability to move by causing
What is dementia? What is dementia? What is dementia? Dementia is an umbrella term for a range of progressive conditions that affect the brain. There are over 200 subtypes of dementia, but the five most
alzheimers.org.uk What is dementia? This factsheet explains what dementia is, including the causes and symptoms, and how it is diagnosed and treated. It also looks at some of the different types of dementia.
onmotor complications radykinesia Screening Tools asked PD micrographia eurodegeneration Designed for Use by Family Practitioners remor on-off opamine agonists tiffness depression ostural instability wearing
The PD You Don t See: Cognitive and Non-motor Symptoms Benzi M. Kluger, M.D., M.S. Associate Professor of Neurology and Psychiatry Director Movement Disorders Center University of Colorado Denver Goals
Concepts in the Evolution of and Treatment Approaches Arnold Bakker, Ph.D. Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine Dementia Criteria for dementia: Memory
5/11/16 PARKINSON S DISEASE Parkinson s disease Prevalence increases with age (starts 40s60s) Seen in all ethnic groups, M:F about 1.5:1 Second most common neurodegenerative disease Genetics role greater
Prof Tim Anderson Neurologist University of Otago Christchurch Tim Anderson Christchurch Insidious cognitive loss From subjective memory complaints (SMC) to dementia Case 1. AR. 64 yrs Male GP referral
PARKINSON S PRIMER Dr. Kathryn Giles MD, MSc, FRCPC Cambridge, Ontario, Canada COPYRIGHT 2017 BY SEA COURSES INC. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted
United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline REV 3/24/09 The UCNS Geriatric Neurology examination was established to determine the level of competence
\ Chapter 15: Late Life and Psychological Disorders 1. Ageism refers to a. the physical deterioration that accompanies old age. b. the intellectual deterioration that frequently occurs as a person ages.
Module 4: Introduction to ID and Dementia Matthew P. Janicki, Ph.D. firstname.lastname@example.org 1 Section Objectives Participants will be able to: Identify how dementia may appear different in adults with ID. Apply
Alzheimer s Disease FACT SHEET Alzheimer s disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest
CARING SHEETS: Caring Sheet #13: Frontotemporal Dementia: A Summary of Information and Intervention Suggestions with an Emphasis on Cognition By Shelly E. Weaverdyck, PhD Introduction This caring sheet
DEMENTIA AND MEDICATION Dr. Siobhan Ni Bhriain, MRCP, MRCPsych. Clinical Director, Tallaght and SJH MHS, Consultant Old Age Psychiatrist, Chair, DSIDC Steering Committee. SUMMARY OF TODAY S TALK Dementia-definition,
Confronting the Clinical Challenges of Frontotemporal Dementia A look at FTD s symptoms, pathophysiology, subtypes, as well as the latest from imaging studies. By Zac Haughn, Senior Associate Editor Ask
Overview of the non-alzheimer Dementias Chiadi U. Onyike, MD, MHS FTD/Young-Onset Dementias Program Johns Hopkins Neuropsychiatry Disclaimer Dr. Onyike is a principal investigator for the Baltimore site
Navigating The Cognitive Internet: Introduction Wendy Lemere DNP, GNP-BC Gerontological Nurse Practitioner Henry Ford Health System What s so hard about diagnosing dementia? Diagnosis relies on synthesis
LANGUAGE IN INDIA Strength for Today and Bright Hope for Tomorrow Volume 8 : 2 February 2008 Managing Editor: M. S. Thirumalai, Ph.D. Editors: B. Mallikarjun, Ph.D. Sam Mohanlal, Ph.D. B. A. Sharada, Ph.D.
Disclosures Research support, Parkinson Society Canada, Canadian Institutes of Health Research, Ministry of Economic Development and Innovation, Teva Novartis clinical trial, Principal Investigator CME
The Future of Alzheimer s Disease Treatment Adam L. Boxer, MD, PhD Director, Alzheimer s Disease Clinical Trials Program Memory and Aging Center Assistant Professor of Neurology University of California,
Corporate Medical Policy Dopamine Transporter Imaging with Single Photon Emission File Name: Origination: Last CAP Review: Next CAP Review: Last Review: dopamine_transporter_imaging_with_single_photon_emission_computed_tomography
agenda genetic counseling genetics 101 genetics of FTD and PPA Lisa Kinsley, MS, CGC, genetic counselor HyungSub Shim, MD, neurology fellow, CNADC how does my fit in? what to expect what is a genetic counselor?
CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE 5.1 GENERAL BACKGROUND Neuropsychological assessment plays a crucial role in the assessment of cognitive decline in older age. In India, there
In-Service Education workbook 3 second edition by Hartman Publishing, Inc. Alzheimer s Disease Dignity Diabetes Restraints and Restraint Alternatives Abuse and Neglect Death and Dying Managing Stress Perf
Decline in Mental Capacity Elder Law: Issues, Answers and Opportunities ALI-ABA, February 23-24, 2006 Robert B. Fleming 1 FLEMING & CURTI, P.L.C. 330 N. Granada Ave. Tucson, Arizona 85701 www.elder-law.com
FOUNDATION OF UNDERSTANDING PARKINSON S DISEASE DEE SILVER M.D MOVEMENT DISORDER SPECIALIST MEDICAL DIRECTOR -- PARKINSON ASSOCIATION OF SAN DIEGO 1980 TO PRESENT SCRIPPS MEMORIAL HOSPITAL, LA JOLLA CA.
Case #1 81-year-old woman Gait Imbalance: Two Unusual Cases in Older Patients February 2008: 3 years of gradually progressive gait imbalance no vertigo, dizziness or paresthesias etiology unclear on examination
Dementia, Assessment, and Caregiver Resources Susan F. Randhawa, M.S.W., L.C.S.W. UCI Institute for Memory Impairments and Neurological Disorders with special thanks to: Malcolm B. Dick, Ph.D. & Cordula
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT RUTH KOHEN ASSOCIATE PROFESSOR UW DEPARTMENT OF PSYCHIATRY 5-4-2017
Mental Health Disorders 2017 Civil Commitment UNC School of Government Edward Poa, MD, FAPA Chief of Inpatient Services, The Menninger Clinic Associate Professor, Baylor College of Medicine NC statutes
A Neurologist s Approach to Altered Mental Status S. Andrew Josephson, MD Department of Neurology University of California San Francisco October 23, 2008 The speaker has no disclosures Case 1 A 71 year-old
Alzheimer s and Dementia Research: An Advanced Discussion Brad Boeve, MD Department of Neurology Mayo Clinic Alzheimer s and Dementia Research: An Advanced Discussion Theoretical Constructs in Aging/Dementia
Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Keith A. Josephs, MD, MST, MSc Professor of Neurology 13th Annual Mild Cognitive Impairment (MCI) Symposium: Alzheimer and Non-Alzheimer
What is Alzheimer s disease Fact Sheet Alzheimer s disease Alzheimer s disease, AD, is a progressive brain disorder that gradually destroys a person s memory and ability to learn, reason, make judgements,
International Symposium on Performance Science ISBN 978-94-90306-01-4 The Author 2009, Published by the AEC All rights reserved Piano playing skills in a patient with frontotemporal dementia: A longitudinal
Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Design of trials in DLB and PDD What has been learnt from previous trials in these indications and other dementias? Overview
Welcome To Brain Health and Risk Factors for Dementia Presented by Kamal Masaki, MD Professor and Chair Department of Geriatric Medicine John A. Burns School of Medicine, UH Manoa April 4, 2018 10:00 11:00
WHO, WHAT, WHEN AND WHERE OF PARKINSON S DIAGNOSIS MJFF Third Thursdays Webinar March 17, 2016 WHAT WE LL COVER TODAY How is Parkinson s misdiagnosed? How is Parkinson s diagnosed today? Can we use DaTscan
Creutzfeldt-Jakob Disease Other Dementias Introduction Alzheimer s disease is one type of a large group of disorders known as dementias. It is an irreversible disease of the brain in which the progressive
UCSF Memory and Aging Center 2016 Best Practices in Mild Cognitive Impairment & Dementia Bruce L. Miller, MD A.W. and Mary Margaret Clausen Distinguished Professor in Neurology Director, Memory and Aging
2013 Alzheimer s disease facts and figures Includes a Special Report on long-distance caregivers 1 in 3 seniors dies with Alzheimer s or another dementia. Out-of-pocket expenses for long-distance caregivers
Dementia With A Twist Christina Tieu Geriatric Update for the Primary Care Provider November 17 th, 2016 2016 MFMER slide-1 79 y/o woman originally from Greece CC: paranoia, abulia and mutism Accompanied
Effective Services for People Living with Brain Injury Jean Capler, MSW, LSW Local Support Network Leader The Rehabilitation Hospital of Indiana Department of Resource Facilitation Plan for Today Brain
Biomarkers: Translating Research into Clinical Practice AFTD Education Conference San Diego, April 2015 Nadine Tatton, PhD Scientific Director, AFTD HelpLine 866-5507-7222 u email@example.com u www.theaftd.org
Parkinson s Disease Update Elise Anderson MD Providence Center for Parkinson s Disease October 26, 2017 11/6/2017 1 Disclosures GE Speaker, DaTSCAN 11/6/2017 2 Outline PD diagnosis Motor and nonmotor symptoms
Delirium, Depression and Dementia Martha Watson, MS, APRN, GCNS Some material included in this presentation is adapted from: NICHE (2009). Geriatric Resource Nurse Core Curriculum [Power Point presentation].
Epilepsy in dementia Dr. Yotin Chinvarun M..D. Ph.D. CEP, PMK hospital Case 1 M 90 years old Had a history of tonic of both limbs (Lt > Rt) at the age of 88 years old, eye rolled up, no grunting, lasting
Early Onset Dementia Y.Hizem, I.Kacem, M.Ben Djebara, I.Belhouan, A.Gargouri, R.Gouider Department of Neurology Razi Hospital - Tunisia Dementing disorders Major public health concern Incidence increasing
PBO 930022142 NPO 049-191 The progression of dementia Although everyone experiences dementia in their own individual way, it can be helpful to think of the progression of dementia as a series of stages.
Multiple choice questions: ANSWERS Chapter 1. Redefining Parkinson s disease 1. Common non-motor features that precede the motor findings in Parkinson s disease (PD) include all of the following except?
Introduction DEMENTIA Dr. Yotin Chinvarun M.D. Ph.D. Neurology, Pramongkutklao hospital In 1901 Auguste Deter, a woman in her early 50s, became 1 st person diagnosed with Alzheimer's disease, a form of
Frontotemporal dementia: Where we ve been What s on the horizon Howard Rosen, M.D. UCSF Department of Neurology Memory and Aging Center www.memory.ucsf.edu None Disclosures Overview FTD, What is it? Origins
Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois http://www.brain.northwestern.edu/dementia/ppa/index.html